Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GST

Setting: Treatment of tuberculosis (TB) can result in Drug-Induced Liver Injury (DILI) since hepatotoxic metabolites are formed during the biotransformation of isoniazid (INH).DILI can be related to the genetic profile of the patient. Single nucleotide polymorphisms in the CYP2E1 gene and GSTM1 and...

Full description

Bibliographic Details
Main Authors: Eliana Abreu Santos, José Carlos Saraiva Gonçalves, Marcos K. Fleury, Afrânio L. Kritski, Martha M. Oliveira, Luciane S. Velasque, José Roberto Lapa e Silva, Rita de Cássia E. Estrela
Format: Article
Language:English
Published: Elsevier 2019-11-01
Series:Brazilian Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1413867019304453
_version_ 1818342015163695104
author Eliana Abreu Santos
José Carlos Saraiva Gonçalves
Marcos K. Fleury
Afrânio L. Kritski
Martha M. Oliveira
Luciane S. Velasque
José Roberto Lapa e Silva
Rita de Cássia E. Estrela
author_facet Eliana Abreu Santos
José Carlos Saraiva Gonçalves
Marcos K. Fleury
Afrânio L. Kritski
Martha M. Oliveira
Luciane S. Velasque
José Roberto Lapa e Silva
Rita de Cássia E. Estrela
author_sort Eliana Abreu Santos
collection DOAJ
description Setting: Treatment of tuberculosis (TB) can result in Drug-Induced Liver Injury (DILI) since hepatotoxic metabolites are formed during the biotransformation of isoniazid (INH).DILI can be related to the genetic profile of the patient. Single nucleotide polymorphisms in the CYP2E1 gene and GSTM1 and GSTT1 deletion polymorphisms have been associated with adverse events caused by INH. Objective: To characterize the genetic polymorphisms of CYP2E1, GSTT1 and GSTM1 in TB carriers. Design: This is an observational prospective cohort study of 45 patients undergoing treatment of TB. PCR-RFLP and multiplex-PCR were used. Results: The distribution of genotypic frequency in the promoter region (CYP2E1 gene) was: 98% wild genotype and 2% heterozygous. Intronic region: 78% wild genotype; 20% heterozygous and 2% homozygous variant. GST enzyme genes: 24% Null GSTM1 and 22% Null GSTT1. Patients with any variant allele of the CYP2E1 gene were grouped in the statistical analyses. Conclusion: Patients with the CYP2E1 variant genotype or Null GSTT1 showed higher risk of presenting DILI (p = 0.09; OR: 4.57; 95% CI: 0.75–27.6). Individuals with both genotypes had no increased risk compared to individuals with one genotype. Keywords: Adverse event, Polymorphisms of CYP2E1 and GST, Induced liver injury from treatment of tuberculosis, Hepatotoxicity, Pulmonary tuberculosis
first_indexed 2024-12-13T16:07:58Z
format Article
id doaj.art-7de2923b93974ba79e283209c56f649d
institution Directory Open Access Journal
issn 1413-8670
language English
last_indexed 2024-12-13T16:07:58Z
publishDate 2019-11-01
publisher Elsevier
record_format Article
series Brazilian Journal of Infectious Diseases
spelling doaj.art-7de2923b93974ba79e283209c56f649d2022-12-21T23:39:00ZengElsevierBrazilian Journal of Infectious Diseases1413-86702019-11-01236381387Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GSTEliana Abreu Santos0José Carlos Saraiva Gonçalves1Marcos K. Fleury2Afrânio L. Kritski3Martha M. Oliveira4Luciane S. Velasque5José Roberto Lapa e Silva6Rita de Cássia E. Estrela7Universidade Federal do Rio de Janeiro, Faculdade de Farmácia, Departamento de Fármacos e Medicamentos, Rio de Janeiro, RJ, Brazil; Corresponding author.Universidade Federal do Rio de Janeiro, Faculdade de Farmácia, Departamento de Fármacos e Medicamentos, Rio de Janeiro, RJ, BrazilUniversidade Federal do Rio de Janeiro, Faculdade de Farmácia, Departamento de Análises Clínicas e Toxicológicas, Rio de Janeiro, RJ, BrazilUniversidade Federal do Rio de Janeiro, Instituto de Doenças do Tórax, Rio de Janeiro, RJ, Brazil; Universidade Federal do Rio de Janeiro, Faculdade de Medicina, Programa Acadêmico de Tuberculose, Rio de Janeiro, RJ, BrazilFundação Oswaldo Cruz, Centro de Desenvolvimento Tecnológico em Saúde, Rio de Janeiro, RJ, BrazilUniversidade Federal do Estado do Rio de Janeiro, Departamento de Matemática e Estatística, Rio de Janeiro, RJ, BrazilUniversidade Federal do Rio de Janeiro, Instituto de Doenças do Tórax, Rio de Janeiro, RJ, Brazil; Universidade Federal do Rio de Janeiro, Faculdade de Medicina, Programa Acadêmico de Tuberculose, Rio de Janeiro, RJ, BrazilUniversidade Federal do Rio de Janeiro, Faculdade de Farmácia, Departamento de Fármacos e Medicamentos, Rio de Janeiro, RJ, Brazil; Fundação Oswaldo Cruz, Instituto Nacional de Doenças Infecciosas Evandro Chagas, Laboratório de Pesquisa Clínica em DST/AIDS, Rio de Janeiro, RJ, BrazilSetting: Treatment of tuberculosis (TB) can result in Drug-Induced Liver Injury (DILI) since hepatotoxic metabolites are formed during the biotransformation of isoniazid (INH).DILI can be related to the genetic profile of the patient. Single nucleotide polymorphisms in the CYP2E1 gene and GSTM1 and GSTT1 deletion polymorphisms have been associated with adverse events caused by INH. Objective: To characterize the genetic polymorphisms of CYP2E1, GSTT1 and GSTM1 in TB carriers. Design: This is an observational prospective cohort study of 45 patients undergoing treatment of TB. PCR-RFLP and multiplex-PCR were used. Results: The distribution of genotypic frequency in the promoter region (CYP2E1 gene) was: 98% wild genotype and 2% heterozygous. Intronic region: 78% wild genotype; 20% heterozygous and 2% homozygous variant. GST enzyme genes: 24% Null GSTM1 and 22% Null GSTT1. Patients with any variant allele of the CYP2E1 gene were grouped in the statistical analyses. Conclusion: Patients with the CYP2E1 variant genotype or Null GSTT1 showed higher risk of presenting DILI (p = 0.09; OR: 4.57; 95% CI: 0.75–27.6). Individuals with both genotypes had no increased risk compared to individuals with one genotype. Keywords: Adverse event, Polymorphisms of CYP2E1 and GST, Induced liver injury from treatment of tuberculosis, Hepatotoxicity, Pulmonary tuberculosishttp://www.sciencedirect.com/science/article/pii/S1413867019304453
spellingShingle Eliana Abreu Santos
José Carlos Saraiva Gonçalves
Marcos K. Fleury
Afrânio L. Kritski
Martha M. Oliveira
Luciane S. Velasque
José Roberto Lapa e Silva
Rita de Cássia E. Estrela
Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GST
Brazilian Journal of Infectious Diseases
title Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GST
title_full Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GST
title_fullStr Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GST
title_full_unstemmed Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GST
title_short Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GST
title_sort relationship of anti tuberculosis drug induced liver injury and genetic polymorphisms in cyp2e1 and gst
url http://www.sciencedirect.com/science/article/pii/S1413867019304453
work_keys_str_mv AT elianaabreusantos relationshipofantituberculosisdruginducedliverinjuryandgeneticpolymorphismsincyp2e1andgst
AT josecarlossaraivagoncalves relationshipofantituberculosisdruginducedliverinjuryandgeneticpolymorphismsincyp2e1andgst
AT marcoskfleury relationshipofantituberculosisdruginducedliverinjuryandgeneticpolymorphismsincyp2e1andgst
AT afraniolkritski relationshipofantituberculosisdruginducedliverinjuryandgeneticpolymorphismsincyp2e1andgst
AT marthamoliveira relationshipofantituberculosisdruginducedliverinjuryandgeneticpolymorphismsincyp2e1andgst
AT lucianesvelasque relationshipofantituberculosisdruginducedliverinjuryandgeneticpolymorphismsincyp2e1andgst
AT joserobertolapaesilva relationshipofantituberculosisdruginducedliverinjuryandgeneticpolymorphismsincyp2e1andgst
AT ritadecassiaeestrela relationshipofantituberculosisdruginducedliverinjuryandgeneticpolymorphismsincyp2e1andgst